Biological background and targets
The estrogen receptors ERα (ESR1) and ERβ (ESR2) are ligand-activated transcription factors in the nuclear receptor superfamily. Reference gene resources and curated annotations are essential when selecting capture/detection antibodies and epitope domains:
-
ESR1 gene summary (ERα): NCBI Gene 2099
-
ESR2 gene summary (ERβ): NCBI Gene 2100
-
Nuclear receptor overview: NIGMS/NIH
-
Estrogen receptor glossary entry: NHGRI/NIH
-
PubMed primary literature search (ER ELISA): PubMed
-
Open full-text studies: PubMed Central (PMC)
Ligand chemistry for reference controls (e.g., 17β-estradiol) and potential small-molecule interferents can be checked in federal repositories:
-
17β-Estradiol record: PubChem (CID 5757)
-
Endocrine disruption context (for background on environmental ligands): EPA Endocrine Disruption
ER ELISA assay formats and epitope strategy
Sandwich ELISA (preferred for ER protein):
-
Capture antibody immobilized to a high-binding plate targets a defined ERα/ERβ epitope (e.g., A/B domain or ligand-binding domain).
-
Detection antibody recognizes a non-overlapping epitope to avoid competition and maximize avidity.
-
Readout via HRP/TMB or AP/PNPP, kinetic or endpoint.
Competitive ELISA (niche use):
-
Useful for limited epitope availability or small-epitope fragments; sensitivity often lower for intact ER protein.
To choose non-overlapping epitopes and avoid cross-reactivity with other keratins, steroid receptors, or splice variants, consult curated domain maps and verified sequences:
-
Protein/gene records and domain features: NCBI Protein
-
MeSH term tree for “Receptors, Estrogen”: NLM MeSH
For general ELISA principles and troubleshooting visuals, university pages are helpful:
-
Conceptual ELISA overview with animations: University of Utah (learn.genetics.utah.edu)
-
ELISA teaching module: Carleton College (carleton.edu)
Sample types and pre-analytical variables
Common matrices: human/animal serum, plasma (EDTA/heparin), cell lysates, tissue lysates. Key pre-analytical controls:
-
Stabilization: Keep samples on ice, minimize freeze-thaw (≤2).
-
Detergent content: For lysates, non-ionic detergents (e.g., 0.1–1% NP-40/Triton X-100) can improve extraction but may affect antibody binding; validate acceptable ranges.
-
Protease/phosphatase inhibitors: Recommended for nuclear receptor integrity.
-
Hemolysis/lipemia/icterus: Evaluate spectral and matrix interference per bioanalytical guidance.
Authoritative method-validation references and vocabulary:
-
FDA Bioanalytical Method Validation (system suitability, stability, acceptance limits): FDA Guidance
-
Assay design fundamentals: Assay Guidance Manual (NIH/NCBI Bookshelf) AGM
Reagents, standards, and calibrators
-
Calibrators: Recombinant ERα and/or ERβ standards with mass verified against a reference; store aliquoted at −80 °C.
-
Matrix-matched standards: Spike calibrators into charcoal-stripped serum or an appropriate surrogate to match binding/viscosity.
-
Controls: At least two independent QC levels (Low/High), preferably three (L/M/H).
-
Traceability: Where possible, reference NIST materials or document traceability chains.
-
NIST SRM program: NIST SRMs
-
Plate coating, blocking, and binding kinetics
-
Coating concentration: 1–10 µg/mL capture antibody in carbonate buffer, pH 9.6; optimize for dynamic range and minimal background.
-
Blocking: BSA (1–5%), casein, or fish gelatin; titrate to reduce non-specific binding without masking epitopes.
-
Incubation: 60–120 min at RT or 16 h at 4 °C for samples and detection antibody; confirm on-plate association/dissociation kinetics via time-course.
Laboratory safety and handling references:
-
CDC biosafety overview: CDC Biosafety in the Lab
-
OSHA laboratory safety: OSHA Laboratory Safety
Detection chemistry and reading parameters
-
HRP/TMB: Measure at 450 nm with 620–650 nm reference; stop solution (e.g., 1 N H₂SO₄) at linear mid-range.
-
AP/PNPP: Measure at 405 nm; slower kinetics but stable signal.
-
Kinetic read can extend dynamic range; ensure linear portion for quantitation.
Instrument method setup guidance and vocabulary standards:
-
NLM resources for analytical terminology: NLM
-
General NIH data resources: NIH Data Sharing/FAIR
Calibration model, LOD/LOQ, and reportable range
Standard curve models:
-
4PL or 5PL nonlinear regression; 5PL often fits asymmetry at low/high ends.
-
Weighting (e.g., 1/y or 1/y²) can stabilize residuals across orders of magnitude.
LOD/LOQ (typical definitions):
-
LOD: Mean blank + 3×SDblank (verify matrix-specific).
-
LOQ: Lowest standard with CV ≤20% and RE within ±20%; define a reportable range with back-calculated standards within acceptance.
Regulatory and best-practice references:
-
FDA bioanalytical validation acceptance limits: FDA Guidance
-
Assay development decision trees and curve fitting: Assay Guidance Manual
Precision, accuracy, recovery, and linearity
Precision:
-
Intra-assay (repeatability): ≥6 replicates per level; target %CV ≤10–15%.
-
Inter-assay (intermediate precision): ≥3 runs/days/operators; target %CV ≤15–20% across levels.
Accuracy/Recovery:
-
Spike-recovery across low/medium/high; target 80–120% recovery unless matrix-specific justification provided.
Linearity/Dilutional parallelism:
-
Serial dilutions (e.g., 1:2 to 1:16) should back-calculate within ±20% of nominal; evaluate parallel slopes vs calibrator curve.
Where to find detailed examples and checklists:
-
Assay verification chapters: Assay Guidance Manual
-
Literature survey for ER assays: PubMed
Specificity and cross-reactivity risk management
-
Orthogonal antibodies: Use capture and detection raised in different species/epitope regions (e.g., N-terminal vs LBD).
-
Blocking peptides (epitope-mapped) to verify signal loss when target epitope is pre-occupied.
-
Counter-screening against related nuclear receptors (AR, PR, GR) to rule out cross-binding.
Terminology and indexing terms to design searches:
-
MeSH browser for “Receptors, Androgen/Progesterone/Glucocorticoid”: NLM MeSH
-
Protein domain info and alignments: NCBI Protein
Matrix effects and interference studies
Assess common interferents per matrix:
-
Serum/plasma: high lipid/protein content; heterophilic antibodies; rheumatoid factor.
-
Lysates: detergents, salts, nucleic acids; verify acceptable ranges by spiking studies.
-
Exogenous small molecules: 17β-estradiol and metabolites at supraphysiological levels are not expected to directly bind anti-ER antibodies but can alter receptor conformation; verify via ligand-pretreated lysates and heat-denaturation controls.
Useful federal chemistry/tox endpoints:
Controls, acceptance criteria, and run validity
Minimum recommended controls for each plate/run:
-
Blank (substrate only).
-
Zero (matrix without analyte).
-
Calibrators (≥6 levels across full range).
-
QCs (L/M/H, duplicates).
-
NSB wells (no primary or no secondary) to quantify non-specific binding.
Run acceptance examples (align to internal SOPs and FDA guidance):
-
≥75% of non-zero standards back-calculate within ±20% (±25% at LLOQ).
-
All QCs within ±20% with %CV ≤20%; at least 2/3 levels passing, including LLOQ QC.
Reference: FDA Bioanalytical Method Validation
Data analysis, documentation, and reproducibility
-
Use validated curve-fit algorithms with audit trails; document plate maps, raw OD, background subtraction, weights, and excluded outliers (with rationale).
-
Ensure data/metadata FAIRness and retention per institutional policy: NIH Data Resources
-
Cite accessioned datasets in GEO/PMC when applicable: NCBI GEO, PMC
Troubleshooting quick index
-
High background: Re-optimize blocking (casein vs BSA), shorten incubation, increase wash stringency; verify plate type.
-
Low signal: Confirm antibody activity on positive control lysate; extend incubation; check substrate freshness and reader gains.
-
Poor parallelism: Increase dilution factor for viscous/complex matrices; switch to matrix-matched calibrators.
-
Drift across plate: Use multichannel technique, equilibrate plate to RT; consider automated washer.
Training-style primers and lab basics:
-
General ELISA concept refresher (edu): University of Utah
-
Lab safety: CDC Laboratory Biosafety
Environmental and occupational considerations
-
Handle acids/bases for stop solutions under appropriate PPE and ventilation (see OSHA): OSHA Laboratory Safety
-
Dispose of chemical/biological waste by institutional policy and local regulations.
-
For potential endocrine-active waste streams, consult EPA guidance: EPA Endocrine Disruption
Example SOP skeleton (copy-adapt for QA)
-
Scope: Quantitative determination of ERα/ERβ in serum, plasma, and mammalian cell/tissue lysates.
-
References: FDA Guidance, Assay Guidance Manual, NIST SRMs, NCBI Gene ESR1, NCBI Gene ESR2.
-
Reagents: Capture/detection mAbs (document clone/lot); recombinant ERα/ERβ calibrators; matrix-matched diluent; TMB; stop solution.
-
Equipment: Calibrated microplate reader (OD 450/620 nm ref), multichannel pipettes, plate washer.
-
Procedure: Coat → block → add samples/QCs/standards → incubate → wash → detect → read.
-
Calibration: 8-point curve (serial 1:2), 5PL weighted fit (1/y²).
-
Acceptance: Standards/QCs within predefined accuracy/precision; blanks/NSB thresholds.
-
Validation: Precision (repeatability/intermediate), accuracy (recovery), specificity, parallelism, stability (bench, freeze-thaw).
-
Records: Plate maps, raw OD files, curve fits, deviation logs, CAPA.
-
Primary keywords: estrogen receptor ELISA, ERα ELISA, ERβ ELISA, estrogen receptor alpha beta sandwich ELISA, ER ELISA kit sensitivity, ER ELISA specificity, ER standard curve, ER LOD LOQ, ER spike recovery.
-
Secondary keywords: nuclear receptor ELISA, steroid receptor assay, matrix effects ELISA, dilutional parallelism, intra-assay CV, inter-assay CV, 4PL 5PL curve, TMB substrate, HRP detection.
-
On-page structure: H1 (this title), H2 sections mirroring the subsections above, internal links to related assays (e.g., PR/AR ELISAs), and external authority links (see the .gov/.edu list embedded throughout).
-
Schema: Add Product/HowTo/TechArticle structured data as appropriate.
-
E-A-T signals: Cite NIH/NCBI, FDA, NIST, EPA, CDC, and reputable .edu training pages (already linked).
-
Media: Include a labeled standard curve figure (4PL/5PL), plate layout, and a short troubleshooting table.
![AffiELISA® Rat Estrogen receptor ELISA [ Esr1]](https://affigen.com/cdn/shop/files/5BAFG-E4345_5D_20AffiELISA_C2_AE_20Cattle_20IFNg_20Kit_20High-Resolution_20Interferon_20Gamma_20ELISA_20Detection_abca2586-b7b5-4a27-bcc9-224c3a03f1c9_535x.png?v=1712840711)

